EGFR and glioblastoma: Frequently altered pathways in cancers involve tyrosine and serine/threonine kinases and relevant receptors, including the epidermal growth factor receptor (EGFR), which alter the regulation of Ras oncogenes overexpressed in glioblastoma (Cancer Genome Atlas Research, 2008).